Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Shiva Rafieian"'
Autor:
Mohsen Gholinataj jelodar, Shahab Rafieian, Fatemeh Saghafi, Navid Hadad zedegan, Behnaz Birjandi, Shiva Rafieian, Azadeh Allah dini, Hanieh Dehghanpour, Fatemeh Khalaj, Samira Zare, Hanieh Dehghan Chenari, Majid Hajimaghsoudi, Seyed Mojtaba Sohrevardi, Samaneh Mirzaei, Tannaz Jamialahmadi, Stephen L. Atkin, Amirhossein Sahebkar
Publikováno v:
International immunopharmacology. 115
This study sought to evaluate and compare the effectiveness of plasmapheresis, Tocilizumab, and Tocilizumab with plasmapheresis treatment on the removal of inflammatory cytokines and improvement clinically of patients with severe COVID-19 in Intensiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::712c8437dfdb68b4c087b4806662ae7a
https://pubmed.ncbi.nlm.nih.gov/36577157
https://pubmed.ncbi.nlm.nih.gov/36577157
Autor:
Hossein Neamatzadeh, Mohammad Hasan Sheikhha, Mohsen Gholi-Nataj, Mohammad Forat Yazdi, Tahereh Nazari, Shiva Rafieian
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 16:6783-6787
BACKGROUND Despite consistent pharmacogenetic effects of CYP2D6 on tamoxifen exposure, there is considerable controversy regarding the validity of CYP2D6 as a predictor of tamoxifen outcome. Understanding the current state of evidence in this area an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f91e76e6e4902c8200656adc3fafb846
https://doi.org/10.7314/apjcp.2015.16.15.6783
https://doi.org/10.7314/apjcp.2015.16.15.6783